DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Pro Medicus Limited

OTCPK:PMCU.F Stock Report

Market Cap: US$12.6b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Pro Medicus Past Earnings Performance

Past criteria checks 5/6

Pro Medicus has been growing earnings at an average annual rate of 42.2%, while the Healthcare Services industry saw earnings growing at 21.8% annually. Revenues have been growing at an average rate of 25.9% per year. Pro Medicus's return on equity is 58.8%, and it has net margins of 101.4%.

Key information

42.18%

Earnings growth rate

42.14%

EPS growth rate

Healthcare Services Industry Growth1.72%
Revenue growth rate25.91%
Return on equity58.85%
Net Margin101.40%
Last Earnings Update30 Jun 2026

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Pro Medicus makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:PMCU.F Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 26262265540
31 Mar 26251250550
31 Dec 25241235550
30 Sep 25227175510
30 Jun 25213115470
31 Mar 25199107450
31 Dec 2418598420
30 Sep 2417391400
30 Jun 2416283390
31 Mar 2415276370
31 Dec 2314270360
30 Sep 2313465340
30 Jun 2312561310
31 Mar 2311556280
31 Dec 2210651250
30 Sep 2210048230
30 Jun 229344220
31 Mar 228741200
31 Dec 218138190
30 Sep 217434180
30 Jun 216831170
31 Mar 216428170
31 Dec 205925170
30 Sep 205824170
30 Jun 205723180
31 Mar 205523180
31 Dec 195422180
30 Sep 195221170
30 Jun 195019160
31 Mar 194717150
31 Dec 184316130
30 Sep 183913130
30 Jun 183410130
31 Mar 18339130
31 Dec 17328120
30 Sep 17329120
30 Jun 17329120
31 Mar 17309120
31 Dec 16288120
30 Sep 16287130
30 Jun 16286130
31 Mar 16255130
31 Dec 15235120
30 Sep 15204110

Quality Earnings: PMCU.F has a high level of non-cash earnings.

Growing Profit Margin: PMCU.F's current net profit margins are higher than last year (54.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PMCU.F's earnings have grown significantly by 42.2% per year over the past 5 years.

Accelerating Growth: PMCU.F's earnings growth over the past year (130.3%) exceeds its 5-year average (42.2% per year).

Earnings vs Industry: PMCU.F earnings growth over the past year (130.3%) exceeded the Healthcare Services industry 14.8%.


Return on Equity

High ROE: PMCU.F's Return on Equity (58.8%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/20 02:40
End of Day Share Price 2026/09/17 00:00
Earnings2026/06/30
Annual Earnings2026/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pro Medicus Limited is covered by 23 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Josh KannourakisBarrenjoey Markets Pty Limited
John HesterBell Potter
Madeleine WilliamsCanaccord Genuity

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide